Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Nuclear Medicine: Page 179
CMS to loosen strings on oncology PET payments
By
Brian Casey
In a move that should make PET reimbursement easier for most oncology applications, the U.S. Centers for Medicare and Medicaid Services (CMS) this week proposed removing its longstanding requirement that FDG-PET scans of patients with solid tumors be reported to a national data registry.
March 13, 2013
PETNet grows Amyvid distribution network
By
AuntMinnie.com staff writers
Siemens Healthcare subsidiary PETNet Solutions has expanded its U.S. manufacturing and distribution network for Eli Lilly's PET tracer Amyvid (florbetapir) to a total of 17 metropolitan areas.
March 13, 2013
FDA clears Navidea's Lymphoseek
By
AuntMinnie.com staff writers
The U.S. Food and Drug Administration announced it has cleared radiopharmaceutical developer Navidea Biopharmaceuticals' Lymphoseek diagnostic imaging agent.
March 12, 2013
Universal Medical to sell DDD gamma cameras
By
AuntMinnie.com staff writers
Universal Medical Resources has signed on to handle U.S. distribution of the CorCam dedicated cardiac gamma camera from Danish nuclear medicine technology developer DDD-Diagnostic.
March 11, 2013
'Unfair' regulatory stance on radiotracers poses threat to PET's future
By
Becky McCall
VIENNA - Legal and regulatory issues surrounding the production and uses of radiotracers represent a significant threat to PET imaging, a senior luminary told ECR 2013 attendees at Sunday's professional challenges session on the legal matters related to multimodality techniques.
March 10, 2013
IBA Molecular starts Zr-89 production in U.S.
By
AuntMinnie.com staff writers
Radiopharmaceutical provider IBA Molecular North America is now producing zirconium-89 (Zr-89) at its radiopharmaceutical plant in Richmond, VA.
March 10, 2013
Collaboration among specialties enhances prospects of cancer patients
By
Becky McCall
VIENNA - Promoting more effective collaboration among radiologists, nuclear medicine physicians, and radiation oncologists to improve imaging and radiotherapy outcomes is a core principle underpinning the lectures in a special focus session on Friday at ECR 2013.
March 7, 2013
FDG-PET/MRI 'comparable' to FDG-PET/CT in head/neck cancer
By
Wayne Forrest
VIENNA - FDG-PET/MRI can produce diagnostic quality images "comparable" to FDG-PET/CT in patients with head and neck cancer, according to a study presented on Thursday during the opening day of ECR 2013.
March 6, 2013
Navidea posts Q4, year-end results
By
AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals has released its fourth quarter and 2012 fiscal year financial results.
March 6, 2013
Lantheus appoints new chief medical officer
By
AuntMinnie.com staff writers
Diagnostic imaging agent developer Lantheus Medical Imaging said it has appointed a new chief medical officer.
March 5, 2013
Mo-99 price decreases affect Nordion's Q1 bottom line
By
AuntMinnie.com staff writers
Decreases in the price of molybdenum-99 (Mo-99) adversely affected Nordion's medical isotope business in the company's first quarter of fiscal 2013.
March 5, 2013
Study shows decline in abnormal stress SPECT MPI
By
Wayne Forrest
Over the past two decades, the frequency and severity of abnormal stress SPECT myocardial perfusion imaging (MPI) studies have significantly decreased, with the prevalence of abnormal SPECT exams falling from 40.9% to 8.7%, researchers reported in the March 5 issue of the
Journal of the American College of Cardiology
.
March 5, 2013
Previous Page
Page 179 of 440
Next Page